Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
<p>Abstract</p> <p>Background</p> <p>Cancer cells have a different metabolic profile compared to normal cells. The Warburg effect (increased aerobic glycolysis) and glutaminolysis (increased mitochondrial activity from glutamine catabolism) are well known hallmarks of c...
Main Authors: | Sun Ramon C, Board Philip G, Blackburn Anneke C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://www.molecular-cancer.com/content/10/1/142 |
Similar Items
-
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
by: Yu Zheng, et al.
Published: (2021-02-01) -
Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh, et al.
Published: (2005-03-01) -
Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases
by: Zhang Y, et al.
Published: (2023-12-01) -
Arsenic Trioxide: Pharmacological Applications
by: German Madrigal Redondo, et al.
Published: (2023-04-01) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Kamran Alimoghaddam
Published: (2014-09-01)